Troyes Ch
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Santagostino, Alberto
VENAZA, NCT06263387: Results From a French Temporary Utilization Authorization of First-line Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (IC), Treated With Venetoclax Azacitidine

Recruiting
N/A
230
Europe
French Innovative Leukemia Organisation, Acute Leukemia French Association
AML, Adult
12/24
03/25
AMMAR, Nadia ALI
FOLLOW, NCT05590702: French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings

Recruiting
N/A
1000
Europe
First line therapy
French Innovative Leukemia Organisation, AbbVie, AstraZeneca, BeiGene, Janssen-Cilag Ltd.
CLL/SLL
11/25
12/32

Download Options